Amalgamated Bank Vaxart, Inc. Transaction History

Amalgamated Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$0.71 - $1.25 $1,320 - $2,325	-1,860 Reduced 11.32%	14,575 $11,000
Q3 2022 Nov 09, 2022	BUY	$2.09 - $4.5 $129 - $279	62 Added 0.38%	16,435 $36,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $5.28 $8,313 - $16,257	-3,079 Reduced 15.83%	16,373 $57,000
Q1 2022 Jun 30, 2022	SELL	$4.29 - $6.64 $6,344 - $9,820	-1,479 Reduced 7.07%	19,452 $98,000
Q4 2021 Feb 15, 2022	SELL	$5.77 - $7.96 $248 - $342	-43 Reduced 0.21%	20,931 $131,000
Q3 2021 Oct 29, 2021	SELL	$6.67 - $9.8 $7,076 - $10,397	-1,061 Reduced 4.82%	20,974 $167,000
Q2 2021 Aug 16, 2021	BUY	$5.06 - $10.78 $111,497 - $237,537	22,035 New	22,035 $165,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.